Terminology Service for NFDI4Health
FOLFIRI/Ramucirumab Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C136251
A chemoimmunotherapy regimen consisting of leucovorin, fluorouracil and irinotecan (FOLFIRI), plus ramucirumab that is used for the treatment of colon cancer. [ ]
Term info
Label
FOLFIRI/Ramucirumab Regimen
Synonyms
- FOLFIRI Plus Cyramza
- FOLFIRI Plus Ramucirumab
- FOLFIRI-Cyramza
- FOLFIRI-Cyramza Regimen
- FOLFIRI-Ramucirumab
- FOLFIRI-Ramucirumab Regimen
- FOLFIRI/Cyramza
- FOLFIRI/Cyramza Regimen
- FOLFIRI/Ramucirumab
- FOLFIRI/Ramucirumab Regimen
- Folinic Acid/Fluorouracil/Irinotecan/Ramucirumab
Subsets
NCIT_C160952, NCIT_C160950
Contributing Source
NCCN
NCI META CUI
CL523562
Preferred Name
FOLFIRI/Ramucirumab Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C136251
Term relations
Subclass of:
- Regimen Used to Treat Colorectal Carcinoma
- Chemotherapy_Regimen_Has_Component some Irinotecan Hydrochloride
- Chemotherapy_Regimen_Has_Component some Ramucirumab
- Regimen_Has_Accepted_Use_For_Disease some Colorectal Carcinoma
- Chemotherapy_Regimen_Has_Component some Fluorouracil
- Chemotherapy_Regimen_Has_Component some Leucovorin Calcium